1. Alarcon WA. Summary of notifiable noninfectious conditions
and disease outbreaks: elevated blood lead levels among
employed adults - United States, 1994-2012. MMWR Morb
Mortal Wkly Rep. 2015;62(54):52-75. doi: 10.15585/mmwr.
mm6254a4.
2. Martins E, Varea A, Apezteguía M, González HF, Girardelli
A, Caro LS, et al. Prenatal lead exposure and relationship
with maternal exposure determinants in a public maternity
hospital of La Plata, Argentina. Sci Total Environ. 2014;473-
474:43-7. doi: 10.1016/j.scitotenv.2013.11.128.
3. Golmohammadi T, Ansari M, Nikzamir A, Safary R, Elahi S.Association of lead concentration in colostrum, maternal and
cord blood with newborn weight in polluted vs. non-polluted
areas of Iran. Tehran Univ Med J. 2007;65(8):74-8. [Persian].
4. Hu H, Téllez-Rojo MM, Bellinger D, Smith D, Ettinger AS,
Lamadrid-Figueroa H, et al. Fetal lead exposure at each stage
of pregnancy as a predictor of infant mental development.
Environ Health Perspect. 2006;114(11):1730-5. doi: 10.1289/
ehp.9067.
5. Masoodi M, Zali MR, Ehsani-Ardakani MJ, MohammadAlizadeh AH, Aiassofi K, Aghazadeh R, et al. Abdominal pain
due to lead-contaminated opium: a new source of inorganic
lead poisoning in Iran. Arch Iran Med. 2006;9(1):72-5.
6. Hayatbakhsh Abbasi MM, Ansari M, Shahesmaeili A, Qaraie
A. Lead serum levels in opium-dependent individuals. Addict
Health. 2009;1(2):106-9.
7. Fatemi R, Jafarzadeh F, Moosavi S, Afshar Amin F. Acute
lead poisoning in an opium user: a case report. Gastroenterol
Hepatol Bed Bench. 2008;1(3):139-42. doi: 10.22037/ghfbb.
v1i3.36.
8. Aghaee-Afshar M, Khazaeli P, Behnam B, Rezazadeh Kermani
M, Ashraf-Ganjooei N. Presence of lead in opium. Arch Iran
Med. 2008;11(5):553-4.
9. Soltaninejad K, Flückiger A, Shadnia S. Opium addiction
and lead poisoning. J Subst Use. 2011;16(3):208-12. doi:
10.3109/14659891.2010.545860.
10. Khatibi-Moghadam H, Khadem-Rezaiyan M, Afshari R.
Comparison of serum and urine lead levels in opium addicts
with healthy control group. Hum Exp Toxicol. 2016;35(8):861-
5. doi: 10.1177/0960327115607947.
11. Soltaninejad K, Shadnia S. Lead poisoning in opium abuser
in Iran: a systematic review. Int J Prev Med. 2018;9:3. doi:
10.4103/ijpvm.IJPVM_22_17.
12. Hayatbakhsh MM, Oghabian Z, Conlon E, Nakhaee S,
Amirabadizadeh AR, Zahedi MJ, et al. Lead poisoning among
opium users in Iran: an emerging health hazard. Subst Abuse
Treat Prev Policy. 2017;12(1):43. doi: 10.1186/s13011-017-
0127-0.
13. Nemati A, Jafari S, Afshari M, Dahmardeh S, Tabrizian K.
Comparing blood lead level among oral/inhaled opium
addicts with a non-addict control group in the southeast of
Iran. Addict Health. 2016;8(4):235-41.
14. Taylor CM, Golding J, Emond AM. Adverse effects of
maternal lead levels on birth outcomes in the ALSPAC study:
a prospective birth cohort study. BJOG. 2015;122(3):322-8.
doi: 10.1111/1471-0528.12756.
15. González-Cossío T, Peterson KE, Sanín LH, Fishbein E,
Palazuelos E, Aro A, et al. Decrease in birth weight in relation
to maternal bone-lead burden. Pediatrics. 1997;100(5):856-
62. doi: 10.1542/peds.100.5.856.
16. Huang S, Hu H, Sánchez BN, Peterson KE, Ettinger AS,
Lamadrid-Figueroa H, et al. Childhood blood lead levels and
symptoms of attention deficit hyperactivity disorder (ADHD):
a cross-sectional study of Mexican children. Environ Health
Perspect. 2016;124(6):868-74. doi: 10.1289/ehp.1510067.
17. Committee on Obstetric Practice. Committee opinion
No. 533: lead screening during pregnancy and lactation.
Obstet Gynecol. 2012;120(2 Pt 1):416-20. doi: 10.1097/
AOG.0b013e31826804e8.
18. Gulson BL, Mizon KJ, Korsch MJ, Palmer JM, Donnelly
JB. Mobilization of lead from human bone tissue during
pregnancy and lactation--a summary of long-term research.
Sci Total Environ. 2003;303(1-2):79-104. doi: 10.1016/
s0048-9697(02)00355-8.
19. Li J, Wang H, Hao JH, Chen YH, Liu L, Yu Z, et al. Maternal
serum lead level during pregnancy is positively correlated
with risk of preterm birth in a Chinese population. Environ
Pollut. 2017;227:484-9. doi: 10.1016/j.envpol.2017.05.009.
20. Amaro H, Fried LE, Cabral H, Zuckerman B. Violence
during pregnancy and substance use. Am J Public Health.
1990;80(5):575-9. doi: 10.2105/ajph.80.5.575.
21. Hutchins E, DiPietro J. Psychosocial risk factors associated
with cocaine use during pregnancy: a case-control study.
Obstet Gynecol. 1997;90(1):142-7. doi: 10.1016/s0029-
7844(97)00181-6.
22. Ebrahim SH, Gfroerer J. Pregnancy-related substance use
in the United States during 1996-1998. Obstet Gynecol.
2003;101(2):374-9. doi: 10.1016/s0029-7844(02)02588-7.
23. Vega WA, Kolody B, Hwang J, Noble A. Prevalence and
magnitude of perinatal substance exposures in California.
N Engl J Med. 1993;329(12):850-4. doi: 10.1056/
nejm199309163291207.
24. Chasnoff IJ, Landress HJ, Barrett ME. The prevalence of illicitdrug or alcohol use during pregnancy and discrepancies in
mandatory reporting in Pinellas county, Florida. N Engl J Med.
1990;322(17):1202-6. doi: 10.1056/nejm199004263221706.
25. Chasnoff IJ, McGourty RF, Bailey GW, Hutchins E, Lightfoot
SO, Pawson LL, et al. The 4P’s Plus screen for substance use
in pregnancy: clinical application and outcomes. J Perinatol.
2005;25(6):368-74. doi: 10.1038/sj.jp.7211266.
26. Kuczkowski KM. Anesthetic implications of drug abuse in
pregnancy. J Clin Anesth. 2003;15(5):382-94. doi: 10.1016/
s0952-8180(03)00056-4.
27. Saleh Gargari S, Fallahian M, Haghighi L, HosseinnezhadYazdi M, Dashti E, Dolan K. Maternal and neonatal
complications of substance abuse in Iranian pregnant women.
Acta Med Iran. 2012;50(6):411-6.
28. Sheehan TJ. Stress and low birth weight: a structural
modeling approach using real life stressors. Soc Sci Med.
1998;47(10):1503-12. doi: 10.1016/s0277-9536(98)00236-
6.
29. Reihani Kermani H, Niktab AR. The relationship between
blood lead concentration and electroneurographic findings in
lead-exposed subjects. J Qazvin Univ Med Sci. 2005;8(4):27-
31. [Persian].
30. Salehi H, Sayadi AR, Tashakori M, Yazdandoost R, Soltanpoor
N, Sadeghi H, et al. Comparison of serum lead level in oral
opium addicts with healthy control group. Arch Iran Med.
2009;12(6):555-8.
31. Amiri M, Amini R. A comparison of blood-lead level (BLL) in
opium-dependant addicts with healthy control group using
the graphite furnace/atomic absorption spectroscopy (GFAAS) followed by chemometric analysis. Iran Red Crescent
Med J. 2012;14(8):488-91.
32. Rahi E, Baneshi MR, Mirkamandar E, Haji Maghsoudi S,
Rastegari A. A comparison between Apgar scores and birth
weight in infants of addicted and non-addicted mothers.
Addict Health. 2011;3(1-2):61-7.
33. Maghsoudlou S, Cnattingius S, Montgomery S, Aarabi M,
Semnani S, Wikström AK, et al. Opium use during pregnancy
and infant size at birth: a cohort study. BMC Pregnancy
Childbirth. 2018;18(1):358. doi: 10.1186/s12884-018-1994-
8.
34. Derakhshan R, Roodpeyma S, Balaee P, Bakhshi H. A
case-control study on perinatal outcomes of opiumaddicted pregnant women and their offsprings in Rafsanjan,
Iran. J Compr Ped. 2014;5(1):e14779. doi: 10.17795/
compreped-14779.
)